Natera (NTRA) Gains from Investment Securities (2014 - 2026)

Natera's (NTRA) quarterly Gains from Investment Securities came in at -$166000.0 in Q1 2026, up 94.87% on a QoQ basis from -$3.2 million in Q2 2025.

Natera (NTRA) Gains from Investment Securities (2014 - 2026) Analysis & Trends

Natera (NTRA) has 8 years of Gains from Investment Securities data on file, last reported at -$166000.0 in Q1 2026.

Quarterly Gains from Investment Securities changed N/A year-over-year to -$166000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.4 million (down 905.92% YoY) and the FY2025 annual result came in at -$3.2 million, changed N/A from the prior year.
Gains from Investment Securities improved to -$166000.0 in Q1 2026, from -$3.2 million in the prior quarter.
In the past five years, Gains from Investment Securities ranged from a high of -$166000.0 in Q1 2026 to a low of -$3.2 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	212.62 Bn	208.56 Bn	8.34 Bn
2	Danaher	139.22 Bn	134.87 Bn	3.61 Bn
3	Idexx Laboratories	46.07 Bn	45.88 Bn	779.09 Mn
4	Agilent Technologies	39.35 Bn	37.54 Bn	990.00 Mn
5	Iqvia Holdings	38.18 Bn	36.10 Bn	1.44 Bn
6	Natera	37.68 Bn	36.58 Bn	696.04 Mn
7	Illumina	28.60 Bn	27.43 Bn	770.00 Mn
8	Mettler Toledo International	28.37 Bn	28.32 Bn	650.22 Mn
9	Quest Diagnostics	26.30 Bn	25.67 Bn	1.03 Bn
10	Labcorp Holdings	25.82 Bn	24.84 Bn	1.01 Bn

Download Data